A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce)
Stopped Tecentriq label restriction for first line limited the patient population and scientific question could not be answered in an appropriate time.
Conditions
Interventions
Sponsor
Hoffmann-La Roche